ESR1 and breast cancer: It has also been demonstrated that ER+ BC cells treated with tamoxifen, results in decreased phosphorylation of STAT3 at serine 727, suggesting an association between tamoxifen sensitivity and decreased STAT3 transcriptional activity (335).